Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 2 |
2021 | 3 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV.
Vaccines (Basel). 2021 Nov 5;9(11):1281. doi: 10.3390/vaccines9111281.
Vaccines (Basel). 2021.
PMID: 34835214
Free PMC article.
Modifications to the HIV-1 SAAVI MVA-C vaccine improve in vitro expression and in vivo immunogenicity.
Douglass N, van Diepen MT, Chapman R, Galant S, Margolin E, Ximba P, Hermanus T, Moore PL, Williamson AL.
Douglass N, et al. Among authors: galant s.
Vaccine. 2021 Jan 15;39(3):463-468. doi: 10.1016/j.vaccine.2020.12.024. Epub 2020 Dec 17.
Vaccine. 2021.
PMID: 33342638
Item in Clipboard
Immunogenicity of HIV-1 Vaccines Expressing Chimeric Envelope Glycoproteins on the Surface of Pr55 Gag Virus-Like Particles.
Chapman R, van Diepen M, Galant S, Kruse E, Margolin E, Ximba P, Hermanus T, Moore P, Douglass N, Williamson AL, Rybicki E.
Chapman R, et al. Among authors: galant s.
Vaccines (Basel). 2020 Jan 29;8(1):54. doi: 10.3390/vaccines8010054.
Vaccines (Basel). 2020.
PMID: 32013223
Free PMC article.
Item in Clipboard
Advancements in the Growth and Construction of Recombinant Lumpy Skin Disease Virus (LSDV) for Use as a Vaccine Vector.
van Diepen M, Chapman R, Douglass N, Whittle L, Chineka N, Galant S, Cotchobos C, Suzuki A, Williamson AL.
van Diepen M, et al. Among authors: galant s.
Vaccines (Basel). 2021 Oct 4;9(10):1131. doi: 10.3390/vaccines9101131.
Vaccines (Basel). 2021.
PMID: 34696239
Free PMC article.
Item in Clipboard
Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus.
van Diepen MT, Chapman R, Douglass N, Galant S, Moore PL, Margolin E, Ximba P, Morris L, Rybicki EP, Williamson AL.
van Diepen MT, et al. Among authors: galant s.
J Virol. 2019 Apr 3;93(8):e02155-18. doi: 10.1128/JVI.02155-18. Print 2019 Apr 15.
J Virol. 2019.
PMID: 30760570
Free PMC article.
Item in Clipboard
Cite
Cite